These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24685546)

  • 21. Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity.
    Yule IA; Czaplewski LG; Pommier S; Davies DT; Narramore SK; Fishwick CW
    Eur J Med Chem; 2014 Oct; 86():31-8. PubMed ID: 25137573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria.
    Lapointe G; Skepper CK; Holder LM; Armstrong D; Bellamacina C; Blais J; Bussiere D; Bian J; Cepura C; Chan H; Dean CR; De Pascale G; Dhumale B; Fisher LM; Fulsunder M; Kantariya B; Kim J; King S; Kossy L; Kulkarni U; Lakshman J; Leeds JA; Ling X; Lvov A; Ma S; Malekar S; McKenney D; Mergo W; Metzger L; Mhaske K; Moser HE; Mostafavi M; Namballa S; Noeske J; Osborne C; Patel A; Patel D; Patel T; Piechon P; Polyakov V; Prajapati K; Prosen KR; Reck F; Richie DL; Sanderson MR; Satasia S; Savani B; Selvarajah J; Sethuraman V; Shu W; Tashiro K; Thompson KV; Vaarla K; Vala L; Veselkov DA; Vo J; Vora B; Wagner T; Wedel L; Williams SL; Yendluri S; Yue Q; Yifru A; Zhang Y; Rivkin A
    J Med Chem; 2021 May; 64(9):6329-6357. PubMed ID: 33929852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus.
    Phillips JW; Goetz MA; Smith SK; Zink DL; Polishook J; Onishi R; Salowe S; Wiltsie J; Allocco J; Sigmund J; Dorso K; Lee S; Skwish S; de la Cruz M; Martín J; Vicente F; Genilloud O; Lu J; Painter RE; Young K; Overbye K; Donald RG; Singh SB
    Chem Biol; 2011 Aug; 18(8):955-65. PubMed ID: 21867911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
    Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
    Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent progress in the discovery and development of DNA gyrase B inhibitors.
    Barančoková M; Kikelj D; Ilaš J
    Future Med Chem; 2018 May; 10(10):1207-1227. PubMed ID: 29787300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition.
    Ismail MMF; Abdulwahab HG; Nossier ES; El Menofy NG; Abdelkhalek BA
    Bioorg Chem; 2020 Jan; 94():103437. PubMed ID: 31812260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.
    Durcik M; Nyerges Á; Skok Ž; Skledar DG; Trontelj J; Zidar N; Ilaš J; Zega A; Cruz CD; Tammela P; Welin M; Kimbung YR; Focht D; Benek O; Révész T; Draskovits G; Szili PÉ; Daruka L; Pál C; Kikelj D; Mašič LP; Tomašič T
    Eur J Med Chem; 2021 Mar; 213():113200. PubMed ID: 33524686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5).
    Singh SB; Kaelin DE; Meinke PT; Wu J; Miesel L; Tan CM; Olsen DB; Lagrutta A; Fukuda H; Kishii R; Takei M; Takeuchi T; Takano H; Ohata K; Kurasaki H; Nishimura A; Shibata T; Fukuda Y
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3630-5. PubMed ID: 26152426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
    Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
    J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.
    Cotman AE; Trampuž M; Brvar M; Kikelj D; Ilaš J; Peterlin-Mašič L; Montalvão S; Tammela P; Frlan R
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28621824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
    Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
    ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV.
    Starr JT; Sciotti RJ; Hanna DL; Huband MD; Mullins LM; Cai H; Gage JW; Lockard M; Rauckhorst MR; Owen RM; Lall MS; Tomilo M; Chen H; McCurdy SP; Barbachyn MR
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5302-6. PubMed ID: 19683922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.
    Charrier C; Salisbury AM; Savage VJ; Moyo E; Forward H; Ooi N; Cheung J; Metzger R; McGarry D; Walker R; Cooper IR; Ratcliffe AJ; Stokes NR
    J Antimicrob Chemother; 2016 Oct; 71(10):2831-9. PubMed ID: 27353465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs).
    Kolarič A; Anderluh M; Minovski N
    J Med Chem; 2020 Jun; 63(11):5664-5674. PubMed ID: 32027491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability.
    Grillot AL; Le Tiran A; Shannon D; Krueger E; Liao Y; O'Dowd H; Tang Q; Ronkin S; Wang T; Waal N; Li P; Lauffer D; Sizensky E; Tanoury J; Perola E; Grossman TH; Doyle T; Hanzelka B; Jones S; Dixit V; Ewing N; Liao S; Boucher B; Jacobs M; Bennani Y; Charifson PS
    J Med Chem; 2014 Nov; 57(21):8792-816. PubMed ID: 25317480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1,2,4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors.
    Mohamed NG; Sheha MM; Hassan HY; Abdel-Hafez LJM; Omar FA
    Bioorg Chem; 2018 Dec; 81():599-611. PubMed ID: 30248511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols.
    Priyanka ; Singh V; Ekta ; Katiyar D
    Bioorg Chem; 2017 Apr; 71():120-127. PubMed ID: 28196603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second-generation 4,5,6,7-tetrahydrobenzo[
    Lamut A; Skok Ž; Barančoková M; Gutierrez LJ; Cruz CD; Tammela P; Draskovits G; Szili PÉ; Nyerges Á; Pál C; Molek P; Bratkovič T; Ilaš J; Zidar N; Zega A; Enriz RD; Kikelj D; Tomašič T
    Future Med Chem; 2020 Feb; 12(4):277-297. PubMed ID: 32043377
    [No Abstract]   [Full Text] [Related]  

  • 39. DNA Topoisomerases as Targets for Antibacterial Agents.
    Hiasa H
    Methods Mol Biol; 2018; 1703():47-62. PubMed ID: 29177732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV.
    Kokot M; Anderluh M; Hrast M; Minovski N
    J Med Chem; 2022 May; 65(9):6431-6440. PubMed ID: 35503563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.